You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

68 Results
Guidelines and Advice
Drug
Other Name(s): Alkeran®
Jun 2019
Drug
Other Name(s): Vesanoid®
Jun 2019
Drug
Other Name(s): Thalomid®
Jun 2019
Drug
Other Name(s): Afinitor®
Jun 2019
Drug
Other Name(s): Purinethol®
Jun 2019
Drug
Other Name(s): Lysodren®
Jun 2019
Drug
Other Name(s): Lanvis®
Jun 2019
Drug
Other Name(s): Zolinza®
Jun 2019
Drug
Other Name(s): Ninlaro™
Jun 2019
Regimen
Cancer Type:
Gastrointestinal, 
Gastrointestinal Stromal Tumours, 
Sarcoma, 
GIST
Intent: Adjuvant
Funding:
ODB - General Benefit
    iMAtinib - Refer to listed Health Canada indications for generic imatinib formulations. Patients must meet generic substitution policies for access to Gleevec®
Oct 2024
Regimen
Cancer Type:
Gastrointestinal, 
Gastrointestinal Stromal Tumours, 
Sarcoma, 
GIST
Intent: Palliative
Funding:
ODB - General Benefit
    iMAtinib - Refer to listed Health Canada indications for generic imatinib formulations. Patients must meet generic substitution policies for access to Gleevec®
Oct 2024

Pages